Clicky

OrthoPediatrics Corp(2X7)

Description: OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.


Keywords: Orthopedic Surgery Sports Medicine Orthopedics Deformity Orthopediatrics Intramedullary Rod Deformity Correction Products Scoliosis Spinal Deformity

Home Page: www.orthopediatrics.com

2850 Frontier Drive
Warsaw, IN 46582
United States
Phone: 574 268 6379


Officers

Name Title
Mr. Mark C. Throdahl Executive Chairman
Mr. David R. Bailey President, CEO & Director
Mr. Fred L. Hite CFO, Principal Financial & Accounting Officer, COO and Director
Mr. Daniel J. Gerritzen J.D. Executive VP of Legal, General Counsel & Secretary
Mr. Gregory A. Odle President of Scoliosis
Mr. Kevin L. Unger CHE, MBA/MSHA President of Enabling Technologies
Mr. Joseph W. Hauser President of Trauma & Deformity Correction
Mr. Joel Batts Senior Vice President of Clinical & Regulatory Affairs
Mr. Mark Karshner Senior Vice President of International Sales

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 1.4651
Price-to-Sales TTM: 2.8056
IPO Date:
Fiscal Year End: December
Full Time Employees: 247
Back to stocks